Fujian Cosunter Pharmaceutical Co., Ltd. (SHE:300436)

China flag China · Delayed Price · Currency is CNY
112.43
-0.44 (-0.39%)
Sep 5, 2025, 2:45 PM CST
-0.39%
Market Cap18.06B
Revenue (ttm)432.14M
Net Income (ttm)-186.95M
Shares Out159.27M
EPS (ttm)-1.17
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume12,041,003
Average Volume16,899,697
Open131.20
Previous Close112.87
Day's Range109.26 - 131.20
52-Week Range17.20 - 188.93
Beta1.24
RSI45.21
Earnings DateAug 28, 2025

About SHE:300436

Fujian Cosunter Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. It offers drugs for anti-HBV, anti-infection, liver diseases, metabolism and digestive system, respiratory, cardiovascular, men’s health, and other fields. Fujian Cosunter Pharmaceutical Co., Ltd. was founded in 2001 and is headquartered in Fuzhou, China. [Read more]

Sector Healthcare
Founded 2001
Employees 760
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300436
Full Company Profile

Financial Performance

In 2024, SHE:300436's revenue was 441.46 million, an increase of 4.43% compared to the previous year's 422.71 million. Losses were -156.30 million, -55.16% less than in 2023.

Financial Statements

News

There is no news available yet.